Citadel Advisors - EKSO BIONICS HLDGS INC ownership

EKSO BIONICS HLDGS INC's ticker is and the CUSIP is 282644301. A total of 34 filers reported holding EKSO BIONICS HLDGS INC in Q3 2022. The put-call ratio across all filers is 2.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of EKSO BIONICS HLDGS INC
ValueSharesWeighting
Q3 2023$33,296
-15.9%
45,424
+64.1%
0.00%
Q2 2023$39,572
-42.5%
27,673
-33.7%
0.00%
Q1 2023$68,845
+64.2%
41,724
+18.5%
0.00%
Q4 2022$41,915
-56.8%
35,223
-43.2%
0.00%
Q3 2022$97,000
-23.0%
62,000
-18.8%
0.00%
Q2 2022$126,000
+215.0%
76,320
+457.1%
0.00%
Q1 2022$40,000
-40.3%
13,700
-45.6%
0.00%
Q4 2021$67,000
-84.0%
25,200
-72.2%
0.00%
Q3 2021$419,000
-38.5%
90,751
-26.6%
0.00%
Q2 2021$681,000
-5.4%
123,670
+6.0%
0.00%
Q1 2021$720,000116,6540.00%
Other shareholders
EKSO BIONICS HLDGS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ESSEX INVESTMENT MANAGEMENT CO LLC 220,513$161,6360.03%
Strategic Wealth Investment Group, LLC 42,665$31,2740.01%
Legato Capital Management LLC 12,038$8,8240.00%
Allworth Financial LP 64$470.00%
VANGUARD GROUP INC 436,925$320,2660.00%
ALBION FINANCIAL GROUP /UT 67$500.00%
UBS Group AG 148$1080.00%
Compagnie Lombard Odier SCmA 25,000$18,3250.00%
Tradewinds Capital Management, LLC 260$1910.00%
Eukles Asset Management 13$100.00%
View complete list of EKSO BIONICS HLDGS INC shareholders